by Marion Nestle

Currently browsing posts about: Sponsored-research

Dec 16 2024

Industry-funded study of the week: Honey

A reader, Colleen Wysocki, sent me a note about this study, the basis of a Nutrition and Dietetics SmartBrief e-mailed to members from the Academy of Nutrition and Dietetics to members.

 RD: Enhance yogurt’s probiotic power with honey…A study in the Journal of Nutrition published earlier this year found that clover honey helps probiotics in yogurt survive longer during digestion, particularly benefiting the probiotic Bifidobacterium animalis…honey adds antioxidants and acts as a protective agent for probiotics. Research advises using just one to two tablespoons of clover honey per serving to optimize probiotic survival.

Here’s the study: Alvarado DA, Ibarra-Sánchez LA, Mysonhimer AR, Khan TA, Cao R, Miller MJ, Holscher HD. Honey Varietals Differentially Impact Bifidobacterium animalis ssp. lactis Survivability in Yogurt through Simulated In Vitro Digestion. J Nutr. 2024 Mar;154(3):866-874. doi: 10.1016/j.tjnut.2024.01.010.

Method: This was an in vitro (petri dish) study of the effects of honey on bacterial counts, with and without the addition of “simulated intestinal fluids.”

Results: “Yogurt with 10-20% wt/wt clover honey increased B. animalis survivability after simulated in vitro digestion (≤ ∼4.7 Log CFU/g survival; P < 0.05).”

Conclusion: “Yogurt with added honey improves probiotic survivability during in vitro digestion.”

Funding: “This work was supported partially by the National Honey Board (HDH and MJM).”

Comment: Honey may be delicious, and no wonder; it is 82% sugar, mostly fructose (41%) and glucose (35%) and not all that different biochemically from sucrose (table sugar).  The reason why the Honey Board funded this study must surely be to demonstrate that adding honey (i.e., sugar) to your yogurt is good for you.  And don’t we all love results like this?

Dec 9 2024

Industry-funded study of the week: Propolis and Mangosteen Extract

Jung J-S, Choi G-H, Lee H, Ko Y, Ji S. The Clinical Effect of a Propolis and Mangosteen Extract Complex in Subjects with Gingivitis: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial. Nutrients 202416(17), 3000; https://doi.org/10.3390/nu16173000

Results:  The results revealed that the PMEC group showed a significantly reduced expression of all measured GCF biomarkers compared to the placebo group (p < 0.0001) at 8 weeks, including substantial reductions in IL-1β, PGE2, MMP-8, and MMP-9 levels compared to the baseline. While clinical parameters trended towards improvement in both groups, the intergroup differences were not statistically significant.

Conclusion: These findings suggest that PMEC consumption can attenuate gingival inflammation and mitigate periodontal tissue destruction by modulating key inflammatory mediators in gingival tissue.

Funding: This research was funded by Medibio Lab Co., Ltd.

Conflicts of interest: The authors declare no conflicts of interest. The authors declare that this study received funding from Lab Co., Ltd. The funders had no role in the design of this study; in the collection, analyses, or interpretation of data; in the writing of this manuscript; or in the decision to publish the results.

Comment: This is a typical industry-funded study in which the authors put a positive interpretation of what appear to be null findings.  I can’t quite tell what this sponsoring company is.  One possibility is MediBioKorea.  Another is Medibios.  Both make supplements.

Nov 25 2024

Industry-funded study of the week: plant-based meat alternatives

Plant-Based Meat Analogs and Their Effects on Cardiometabolic Health: An 8-Week Randomized Controlled Trial Comparing Plant-Based Meat Analogs With Their Corresponding Animal-Based Foods. Toh DWK, Fu AS, Mehta KA, Lam NYL, Haldar S, Henry CJ. Am J Clin Nutr. 2024 Jun;119(6):1405-1416. doi: 10.1016/j.ajcnut.2024.04.006. Epub 2024 Apr 8.

Erratum in: Am J Clin Nutr. 2024 Aug;120(2):459. doi: 10.1016/j.ajcnut.2024.06.012.

This study compared effects on cardiometabolic health among people eating meat or plan-based alternatives for 8 weeks.

Conclusion: An 8-wk PBMA (plant-based) diet did not show widespread cardiometabolic health benefits compared with a corresponding meat based diet.

Funding: This study was supported by Pinduoduo Incorporated (HongKong Walnut Street Limited). Pinduoduo Incorporated had no role in study design, study conduct, laboratory analyses, data collection, management and interpretation or the writing, reviewing and approval of the manuscript.

Comment

This study was sent to me by a reader, who viewed it as a rare example of an industry-funded study with results unfavorable to the sponsor’s interests.  He thought the “Walnut” in the company’s name indicated a plant-based bias.

I wasn’t so sure and wondered what Pinduoduo did, exactly.

According to Wikipedia, “Pinduoduo Inc. (Chinese拼多多Pinyin: Pīn duōduō) is a Chinese online retailer with a focus on the traditional agriculture industry. The business is the largest product of PDD Holdings, which also owns the online marketplace Temu.”

But it gets even better.  The American Journal of Clinical Nutrition published a correction to the paper:

The original funding statement was insufficiently elaborated and has been revised for greater clarity: Christiani Jeyakumar Henry [the senior investigator on this study] reports partial financial support provided by Pinduoduo Incorporated (HongKong Walnut Street Limited) which is an agricultural research firm.

This, then, is a standard example of an industry-funded—and conducted—study producing just the results wanted.  Another example of marketing research, alas.

Nov 18 2024

Industry-funded study of the week: microalgae of all things

No food industry is too small or too obscure to fund research in its own interest.  Try this one, for example.

Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline. Yoo C, Maury J, Gonzalez DE, Ko J, Xing D, Jenkins V, Dickerson B, Leonard M, Estes L, Johnson S, et al.  Nutrients. 2024; 16(17):2999. https://doi.org/10.3390/nu16172999

Background: Phaeodactylum tricornutum (PT) is a microalgae extract that contains fucoxanthin and has been shown to enhance cognitive function in younger populations.

Purpose: The present study assessed if PT supplementation affects cognition in healthy, young-old, physically active adults with self-perceptions of cognitive and memory decline.

Methods: Forty-three males and females…with perceptions of cognitive and memory decline completed the double-blind, randomized, parallel-arm, placebo-controlled intervention clinical trial. Participants were…randomly allocated to their respective 12-week supplementation interventions, which were either the placebo (PL) or 1100 mg/day of PT containing 8.8 mg of fucoxanthin (FX).

Results: FX supplementation significantly affected (p < 0.05) or exhibited tendencies toward significance (p > 0.05 to p < 0.10 with effect sizes ranging from medium to large) for word recall, picture recognition reaction time, Stroop color–word test, choice reaction time, and digit vigilance test variables.

Conclusions: The results demonstrate some evidence that FX supplementation can improve working and secondary memory, vigilance, attention, accuracy, and executive function.

Funding: Microphyt (Baillargues, FRA) funded this study through a grant (Microphyt #410991) to Texas A&M University.

Conflicts of interest: J.M. and R.P. are sponsor-affiliated researchers who therefore have conflicts of interest in study results. They provided input on study design but were not involved in data collection or analysis. R.B.K. has conducted grant and contract-funded research on nutritional supplements awarded to the universities he has been affiliated with, received an honorarium for making scientific presentations, and served as a paid scientific expert. He has no financial conflicts of interest with the study sponsor or product evaluated in this study. The remaining coauthors report no financial conflicts of interest.

Comment: I like “some evidence.”  That suggests the evidence is not particularly impressive.  The study found positive conclusions, not surprising since two of the authors work for the sponsoring company.  Industry-funded studies almost invariably find conclusions that favor the sponsor’s interests.  Otherwise, why bother to sponsor research.  That’s its point: marketing.

Nov 11 2024

Industry-funded review of the week: strawberries (off season)

Thanks to Stephen Zwick of Regenetarianism for sending this one.

Charoenwoodhipong, P., Zuelch, M. L., Keen, C. L., Hackman, R. M., & Holt, R. R. (2024). Strawberry (Fragaria x Ananassa) intake on human health and disease outcomes: a comprehensive literature reviewCritical Reviews in Food Science and Nutrition, 1–31. https://doi.org/10.1080/10408398.2024.2398634

From the Abstract

Of the 60 articles included in this review, 47 were clinical trials, while 13 were observational studies. A majority of these studies reported on the influence of strawberry intake on cardiometabolic outcomes. Study designs included those examining the influence of strawberry intake during the postprandial period, short-term trials randomized with a control, or a single arm intake period controlling with a low polyphenolic diet or no strawberry intake. A smaller proportion of studies included in this review examined the influence of strawberry intake on additional outcomes of aging including bone and brain health, and cancer risk. Data support that the inclusion of strawberries into the diet can have positive impacts during the postprandial period, with daily intake improving outcomes of lipid metabolism and inflammation in those at increased cardiovascular risk.

Funding: This work was supported by the California Strawberry Commission (CSC). PC, MLZ, and RRH received financial support from the CSC for this work.

Disclosure statement: No potential conflict of interest was reported by the authors.

Comment: I can never get over how industry-funded authors do not view industry funding as a conflict of interest when so much evidence confirms that such funding strongly influences research design and interpretation.  For the record, I review that evidence in my book Unsavory Truth: How Food Companies Skew the Science of What We Eat.

This sure looks like a standard industry-funded study with a predictable outcome favorable to the strawberry industry in this case.

Strawberries are a fine food, delicious, nutritious, and obviously healthful.  But a superfood responsible on their own for disease prevention?

How I wish.

This is marketing research.

Nov 4 2024

Industry partnership of the week: Kentucky Beef and Public Health Associations

A reader sent me this e-mailed announcement from the Kentucky Public Health Association. 

The announcement features “hot off the press” research.

More Information

For more information, visit The Kentucky Beef Council and Beef It’s What’s For Dinner.
For infographics and nutrition handouts, click here.
To join our monthly health professional newsletter, register here.

COMMENT

This advertisement from the Kentucky Beef Council was sent to members of the Kentucky Public Health Association.  It does not say who sponsored the hot new research [I had to look it up].

The partnership raises several questions:

  • Is the Kentucky Beef Council a sponsor of the Association?  If so, at what level? (Its annual report does not list sponsors.  Neither does its website, although it does list sponsorship categories for its annual meetings).
  • Do members of the Kentucky Public Health Association believe that their association’s apparent endorsement of beef is a good idea?
  • Are Kentucky public health nutritionists talking to their clients about the role of beef in health and environmental sustainability?
  • If so, what are they saying?

The benefit of this kind of sponsorship/partnership to the Kentucky Beef Council is obvious.

But it raises serious questions about the integrity of the Kentucky Public Health Association.

I hope KPHA members are discussing this issue with the Association’s leadership.

Oct 21 2024

Industry-funded study of the week: again, potatoes

Potatoes, a source of rapidly absorbable starch, have such a bad reputation that some nutritionists advise against eating them.  I am not one of them.  I enjoy eating potatoes and think their blood sugar-raising effects depend on how they are prepared and how muh of them you eat.

The potato industry, alarmed about advice not to eat potatoes, funds research to prove they are healthy, or at least do no harm.  Hence:

Djousse L, Zhou X, Lim J, Kim E, Sesso HD, Lee IM, Buring JE, McClelland RL, Gaziano JM, Steffen LM, Manson JE. Potato Consumption and Risk of Type 2 Diabetes Mellitus: A Harmonized Analysis of 7 Prospective Cohorts. J Nutr. 2024 Oct;154(10):3079-3087. doi: 10.1016/j.tjnut.2024.07.020.

  • Results: In the primary analysis, total potato intake was not associated with T2D risk:…In secondary analyses, consumption of combined baked, boiled, and mashed potatoes was not associated with T2D risk, whereas fried potato consumption was positively associated with T2D risk:.
  • Conclusions: Although consumption of total potato is not associated with T2D risk, a modest elevated risk of T2D is observed with fried potato consumption.
  • Conflict of interest: LD received investigator-initiated grant from the Alliance for Potato Research and Education (as principal investigator).
  • Funding: This project was supported by a grant from the Alliance Potato Research and Education (principal investigator: LD).  A lengthy list of other funders, including NIH and Mars Edge, follows.

Comment: This potato industry-funded study did not find potatoes to be associated with type 2 diabetes, which must be a huge relief to this industry. But the study did find a weak association (barely statistically significant) beween fried potatoes and type 2 diabetes.  The Potato Alliance ought to be delighted with this result.   I’m guessing the result is real (it’s what I would have predicted), but I’d be happier with it if it had been conducted by investigators independent of industry funding.  As it is, it looks like the potato industry got what it paid for.

Oct 7 2024

Industry-funded opinion of the week: Forget about ultra-processed

A reader, Bart Peuchot, writes:

I would be very interested to have your view on this new publication for Nature.

As you taught me, I checked the competing interests and it seems to be a perfect industry-funded publication.

And then ,I ran across this Tweet (X) from @Stuart Gillespie:

New paper concluding “more research needed”
…brought to you by Nutrition Foundation of Italy…
…which in turn is brought to you by
…..@Nestle @McDonalds @CocaCola Ferrero, Barilla, Danone et al…

Well.  What  is this about?

I went right to the paper: Visioli, F., Del Rio, D., Fogliano, V. et al. Ultra-processed foods and health: are we correctly interpreting the available evidence?. Eur J Clin Nutr (2024). https://doi.org/10.1038/s41430-024-01515-8

Aha! Another attack on the concept of ultra-processed foods.  The article concludes

the available evidence on how different UPFs have been associated with health, as well as the results of studies examining specific food additives, call into question the possibility that ultra-processing per se is the real culprit. It is possible that other unaccounted for confounding factors play an important role. Future, urgently needed studies will clarify this issue.

The Italian food industry has been especially active in opposing NutriScore labels and anything else that might discourage sales of foods high in sugar, salt, and saturated fat.

But it is not alone in pushing back against the concept of  ultra-processed foods—an existential threat to junk food manufacturers.

Here, for example, is Hank Cardello,  the Executive Director of Leadership Solutions for Health + Prosperity at Georgetown’s Business School writing in Forbes:: New Report Highlights The Sweet Side Of Ultra-Processed Foods.

With ultra-processed foods (UPFs) replacing “junk food” as the new bogeyman for public health advocates, a new study published by  the Georgetown University Business for Impact Center (full disclosure: I am one of the authors) reveals that all UPFs are not created equal. The report spotlighted that candy in particular was the exception, since that category contributes only 6.4% of added sugars and less than 2% of our calories. The most surprising discovery is that the “healthiest of the healthiest” consumer cohort in the study purchased candy 26% more frequently than the general population.

The report: New Consumer Insights on Ultra-Processed Indulgent Foods: How Confectionery Products Are Different.

Candy behaves differently from other ultraprocessed indulgent products. New NMI and NHANES data re-confirm that candy is different and should not be lumped together with other indulgent products. Consumers do not overconsume  chocolate and candy, so targeting these foods will not impact obesity. An approach that focuses on product categories that consumers with the highest BMIs eat and drink the most will be more effective.

OK, readers: Take a guess at who paid for this.

Funding for this paper was provided by the National Confectioners Association.

As I keep saying, you can’t make this stuff up.